Atomo Diagnostics responds to ASX price query
Key points
- Company not aware of any price-sensitive information not yet announced
- Confirmed compliance with Listing Rules, including Listing Rule 3.1
- Responses authorized and approved by the Board
Full summary
Atomo Diagnostics Limited has responded to an ASX price query regarding the recent trading in its securities. The company stated that it is not aware of any price-sensitive information that has not been announced, which could explain the recent trading. Atomo Diagnostics confirmed that it is in compliance with the disclosure provisions of the Listing Rules, particularly Listing Rule 3.1. The company also confirmed that the responses to the ASX's queries have been authorized and approved by the Board. Atomo Diagnostics provided a detailed response addressing the ASX's specific questions and requests for information, demonstrating its commitment to transparent and compliant disclosure practices.
Summary generated by a large language model. Please interpret with care.